Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Prolonged isolated thrombocytopenia (PT) after allogeneic stem cell transplantation (allo-SCT) has a great impact on transplant outcome. In this study, we performed a retrospective analysis to investigate the association of donor-specific anti-human leukocyte antigen (HLA) antibodies (DSAs) with PT...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaosu Zhao, Xiangyu Zhao, Mingrui Huo, Qiaozhen Fan, Xuying Pei, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaojun Huang, Kaiyan Liu, Yingjun Chang
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/1043836
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556203913248768
author Xiaosu Zhao
Xiangyu Zhao
Mingrui Huo
Qiaozhen Fan
Xuying Pei
Yu Wang
Xiaohui Zhang
Lanping Xu
Xiaojun Huang
Kaiyan Liu
Yingjun Chang
author_facet Xiaosu Zhao
Xiangyu Zhao
Mingrui Huo
Qiaozhen Fan
Xuying Pei
Yu Wang
Xiaohui Zhang
Lanping Xu
Xiaojun Huang
Kaiyan Liu
Yingjun Chang
author_sort Xiaosu Zhao
collection DOAJ
description Prolonged isolated thrombocytopenia (PT) after allogeneic stem cell transplantation (allo-SCT) has a great impact on transplant outcome. In this study, we performed a retrospective analysis to investigate the association of donor-specific anti-human leukocyte antigen (HLA) antibodies (DSAs) with PT in 394 patients who underwent unmanipulated haploidentical blood and marrow transplantation (HBMT). For HLA antibody positive samples with a median fluorescent intensity (MFI) > 500, DSAs were further examined. A total of 390 patients (99.0%) achieved sustained myeloid engraftment. Of the 394 cases tested, 45 (11.4%) were DSA positive. The cumulative incidence of PT in this cohort of patients was 9.9 ± 1.5%. The incidence of PT was higher in patients with a MFI ≥ 1000 compared with those with a MFI < 1000 (16.8 ± 6.4% versus 7.4 ± 1.4%, P=0.05). Multivariate analysis showed that the presence of DSAs (MFI ≥ 1000) was correlated to PT (hazard ratio (HR) 3.262; 95% confidence interval (CI), 1.339–7.946; P=0.009) and transplant-related mortality (HR 2.320; 95% CI, 1.169–4.426; P=0.044). Our results, for the first time, suggest an association of DSAs with PT after unmanipulated HBMT. It would help screen out the suitable donor and guide intervention. This indicated that DSAs should be incorporated in the algorithm for unmanipulated HBMT.
format Article
id doaj-art-972139ff30d14d1fa3de254fea1504dc
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-972139ff30d14d1fa3de254fea1504dc2025-02-03T05:46:00ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/10438361043836Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell TransplantationXiaosu Zhao0Xiangyu Zhao1Mingrui Huo2Qiaozhen Fan3Xuying Pei4Yu Wang5Xiaohui Zhang6Lanping Xu7Xiaojun Huang8Kaiyan Liu9Yingjun Chang10Peking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaPeking University People’s Hospital and Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, No. 11 South Street of Xizhimen, Xicheng District, Beijing 100044, ChinaProlonged isolated thrombocytopenia (PT) after allogeneic stem cell transplantation (allo-SCT) has a great impact on transplant outcome. In this study, we performed a retrospective analysis to investigate the association of donor-specific anti-human leukocyte antigen (HLA) antibodies (DSAs) with PT in 394 patients who underwent unmanipulated haploidentical blood and marrow transplantation (HBMT). For HLA antibody positive samples with a median fluorescent intensity (MFI) > 500, DSAs were further examined. A total of 390 patients (99.0%) achieved sustained myeloid engraftment. Of the 394 cases tested, 45 (11.4%) were DSA positive. The cumulative incidence of PT in this cohort of patients was 9.9 ± 1.5%. The incidence of PT was higher in patients with a MFI ≥ 1000 compared with those with a MFI < 1000 (16.8 ± 6.4% versus 7.4 ± 1.4%, P=0.05). Multivariate analysis showed that the presence of DSAs (MFI ≥ 1000) was correlated to PT (hazard ratio (HR) 3.262; 95% confidence interval (CI), 1.339–7.946; P=0.009) and transplant-related mortality (HR 2.320; 95% CI, 1.169–4.426; P=0.044). Our results, for the first time, suggest an association of DSAs with PT after unmanipulated HBMT. It would help screen out the suitable donor and guide intervention. This indicated that DSAs should be incorporated in the algorithm for unmanipulated HBMT.http://dx.doi.org/10.1155/2017/1043836
spellingShingle Xiaosu Zhao
Xiangyu Zhao
Mingrui Huo
Qiaozhen Fan
Xuying Pei
Yu Wang
Xiaohui Zhang
Lanping Xu
Xiaojun Huang
Kaiyan Liu
Yingjun Chang
Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
Journal of Immunology Research
title Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
title_full Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
title_fullStr Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
title_full_unstemmed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
title_short Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
title_sort donor specific anti human leukocyte antigen antibodies predict prolonged isolated thrombocytopenia and inferior outcomes of haploidentical hematopoietic stem cell transplantation
url http://dx.doi.org/10.1155/2017/1043836
work_keys_str_mv AT xiaosuzhao donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT xiangyuzhao donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT mingruihuo donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT qiaozhenfan donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT xuyingpei donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT yuwang donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT xiaohuizhang donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT lanpingxu donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT xiaojunhuang donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT kaiyanliu donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation
AT yingjunchang donorspecificantihumanleukocyteantigenantibodiespredictprolongedisolatedthrombocytopeniaandinferioroutcomesofhaploidenticalhematopoieticstemcelltransplantation